Policy implications of the potential use of a novel vaccine to prevent infection with Schistosoma mansoni with or without mass drug administrationKlodeta Kura, Roy M. Anderson, T. Déirdre Hollingsworth et al.|Vaccine|2020Cited by 17
Individual longitudinal compliance to neglected tropical disease mass drug administration programmes, a systematic reviewRosie Maddren, Roy M. Anderson, Kathryn Forbes et al.|PLoS neglected tropical diseases|2023Cited by 16
How Does the Proportion of Never Treatment Influence the Success of Mass Drug Administration Programs for the Elimination of Lymphatic Filariasis?Klodeta Kura, Luc E. Coffeng, Wilma A. Stolk et al.|Clinical Infectious Diseases|2024Cited by 14
The observed relationship between the degree of parasite aggregation and the prevalence of infection within human host populations for soil-transmitted helminth and schistosome infectionsKlodeta Kura, Roy M. Anderson, James E. Truscott et al.|Transactions of the Royal Society of Tropical Medicine and Hygiene|2022Cited by 11
How Does Treatment Coverage and Proportion Never Treated Influence the Success of <i>Schistosoma mansoni</i> Elimination as a Public Health Problem by 2030?Klodeta Kura, Roy M. Anderson, Luc E. Coffeng et al.|Clinical Infectious Diseases|2024Cited by 7